Bryan S. K. Kim
University of Hawaii at Manoa
H-index: 62
North America-United States
Top articles of Bryan S. K. Kim
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Estimating meaningful change thresholds for Skin Pain‐Numeric Rating Scale, Sleep‐Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis | Journal of the European Academy of Dermatology and Venereology | S Stander BS Kim I Guillemin S Rhoten S Wratten | 2024/2/8 |
526-Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study | British Journal of Dermatology | Andrew Blauvelt Marjolein de Bruin-Weller Shawn G Kwatra Melinda J Gooderham Brian Kim | 2024/2 |
Dupilumab improves itch in patients with prurigo nodularis regardless of baseline Ige | Revue Française d'Allergologie | MN Crépy BS Kim S Ständer G Yosipovitch CH Hong | 2024/4/1 |
Cutaneous Components Leading to Pruritus, Pain, and Neurosensitivity in Atopic Dermatitis: A Narrative Review | Sonja Ständer Thomas Luger Brian Kim Ethan Lerner Martin Metz | 2024/1/6 | |
542-Validation of the skin pain numerical rating scale of the Pruritus and Symptoms Assessment for Atopic Dermatitis for adults and adolescents with moderate-to-severe atopic … | British Journal of Dermatology | Jonathan I Silverberg Sonja Ständer Brian S Kim Anthony Bewley Laurent Misery | 2024/2 |
529-Worsening of itch before flaring in patients with moderate-to-severe atopic dermatitis treated with abrocitinib: a post hoc analysis of the phase 3 JADE REGIMEN trial | British Journal of Dermatology | Jonathan I Silverberg Brian S Kim Marjolein de Bruin-Weller Stephan Weidinger Martin Steinhoff | 2024/2 |
Increased systemic levels of centrally acting B-type Natriuretic Peptide are associated with chronic Itch of different types | Journal of Investigative Dermatology | Leigh A Nattkemper Brian S Kim Qai Ven Yap Mark A Hoon Santosh K Mishra | 2024/3/22 |
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis | Nature | Nelson M LaMarche Samarth Hegde Matthew D Park Barbara B Maier Leanna Troncoso | 2024/1/4 |
Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2) | JAAD International | Gil Yosipovitch Brian S Kim Shawn G Kwatra Nicholas K Mollanazar Sonja Ständer | 2024/4/10 |
512-Dupilumab treatment improves satisfaction in patients with prurigo nodularis who did not achieve the multicomponent endpoint: analysis from LIBERTY-PN PRIME and PRIME2 | British Journal of Dermatology | Shawn G Kwatra Gil Yosipovitch Sonja Ständer Pedro Mendes-Bastos Tsen-Fang Tsai | 2024/2 |
JAK1 inhibitors and uses thereof | 2024/3/19 | ||
Dupilumab Reduction of IgE Levels and Probability of Atopic Dermatitis Flares–Analysis of A Randomized Placebo-Controlled 52-Week Study | Journal of Allergy and Clinical Immunology | Brian Kim Lisa Beck Eric Simpson Lawrence Eichenfield Jonathan Silverberg | 2024/2/1 |
Sensory neurons promote immune homeostasis in the lung | Cell | Masato Tamari Kate L Del Bel Aaron M Ver Heul Lydia Zamidar Keisuke Orimo | 2024/1/4 |
Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to … | Dermatology | Jacob P Thyssen Anthony Bewley Sonja Ständer Carla Castro Laurent Misery | 2024/4/4 |
510-Dupilumab is efficacious in patients with prurigo nodularis regardless of stable use of topical corticosteroids and topical calcineurin inhibitors: pooled results from two … | British Journal of Dermatology | Brian S Kim Gil Yosipovitch Shawn G Kwatra Sonja Ständer Nicholas Mollanazar | 2024/2 |
Learning from nemolizumab: A promising therapy for prurigo nodularis | Journal of Allergy and Clinical Immunology | Brian S Kim | 2024/3/7 |
Rapid Reduction and Free or Almost Free of Itch Response With Oral Difelikefalin in Subjects With Notalgia Paresthetica and Moderate-to-Severe Pruritus | SKIN The Journal of Cutaneous Medicine | Mark Lebwohl Brian S Kim Javier Alonso-Llamazares Zoe Diana Draelos Kristine Nograles | 2024/1/16 |
Reviews and feature articles | Tuomas Jartti James E Gern Michael R Edwards Katherine Strong Aoife Cameron | 2017 | |
RAG suppresses group 2 innate lymphoid cells | bioRxiv | Aaron Ver Heul Madison Mack Lydia Zamidar Masato Tamari Ting-Lin Yang | 2024 |
506-Dupilumab is efficacious in patients with prurigo nodularis regardless of history of atopic comorbidities: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2) | British Journal of Dermatology | Brian S Kim Margarida Gonçalo Tsukasa Ugajin Amy Praestgaard Melanie Makhija | 2024/2 |
